A beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate CEP of the European Pharmacopoeia monograph is often referred to as a beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate Certificate of Suitability (COS). The purpose of a beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate to their clients by showing that a beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate CEP has been issued for it. The manufacturer submits a beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate CEP (COS) as part of the market authorization procedure, and it takes on the role of a beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate CEP holder for the record. Additionally, the data presented in the beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate DMF.
A beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of beta-D-Mannopyranose 1,3,4,6-tetra-O-acetate 2-O-trifluoromethanesulfonate suppliers with CEP (COS) on PharmaCompass.